Biomarkers in feces could replace colonoscopies

Thanks to research perform by veterinarians, unpleasant colonoscopies could possibly be relegated to the barbaric past. University of Missouri researchers, including those at the College of Veterinary Medicine, have discovered biomarkers in mouse feces that predicted inflammation-associated colon cancer. The hope is that feces screening could replace colonoscopies in the future. "Many people put off colonoscopies longer than they should because of the invasiveness and unpleasant nature of the exam, and it's not pleasant for mice either," Aaron Ericsson, a post-doctoral researcher at MU, told DVM Newsmagazine. "That unpleasantness is negated with this test." (Of course, this study follows previous development of a stool-based DNA test for colon cancer at Exact Sciences.) Story

Suggested Articles

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.

The dream of a comfortable, tabletop blood testing device, needing only a few drops taken from a finger and a handful of minutes, has now arrived.

Novartis is now teaming up with Amazon’s mammoth cloud computing division to overhaul its manufacturing, supply and business operations.